Peterson Kristine 4
4 · ImmunoGen, Inc. · Filed Dec 5, 2023
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Peterson Kristine
Director
Transactions
- Exercise/Conversion
Common Stock
2023-11-30$13.07/sh+10,000$130,700→ 20,000 total - Sale
Common Stock
2023-11-30$28.90/sh−20,000$578,000→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-11-30−10,000→ 0 totalExercise: $10.10Exp: 2024-11-11→ Common Stock (10,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2023-11-30−10,000→ 0 totalExercise: $13.07Exp: 2025-11-10→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2023-11-30$10.10/sh+10,000$101,000→ 10,000 total
Footnotes (4)
- [F1]Effected pursuant to a trading plan adopted on June 11, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.80 to $29.25, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.
- [F3]This option was granted on 11/11/2014 and is fully vested as of the transaction date.
- [F4]This option was granted on 11/10/2015 and is fully vested as of the transaction date.